EDITOR'S CHOICE

  • New pulmonary embolism treatments offer patients freedom from needles

    Treatments for pulmonary embolisms (PE) will evolve to better suit patient needs and enhance their quality of life, according to a report by GlobalData.

    EDITOR'S CHOICE | 24 May 2012

  • Pharmaceutical giants set to lose dominance in urological disorders market

    Major pharmaceutical companies are predicted to lose their footing in the urological disorders market by 2017, a report by GBI Research has found.

    EDITOR'S CHOICE | 17 May 2012

  • AB SCIEX opens scientific hub in Singapore

    AB SCIEX announced that it has opened its new APAC Regional Application & Training Centre in Biopolis. This move fortifies the company’s focus on Singapore as a base for supporting a rising concentration of scientists across Asia Pacific using mass spectrometry.

    EDITOR'S CHOICE | 26 April 2012

  • Panasonic expands healthcare offering

    Panasonic announced the creation of a new business: Panasonic Biomedical Sales Europe BV (PHCBEU). The new organization sees Sanyo E&E Europe BV re-brand as PHCBEU and continues to offer a wide range of biomedical products.

    EDITOR'S CHOICE | 17 April 2012

  • ICON acquires PriceSpective

    The acquisition strengthens ICON’s expertise in value based pricing and market access.

    EDITOR'S CHOICE | 05 April 2012

  • BiotechCorp, Quintiles collaborate

    Quintiles solidified the partnership with BiotechCorp, signifying interests in the areas of shared services central laboratory and biobank, clinical research graduate/internship training program, stem cell research and national vaccine hub.

    EDITOR'S CHOICE | 02 April 2012

  • Pharmaceutical circulation enterprises see relatively low profit margin in China

    In China, pharmaceutical circulation enterprises see relatively low profit margin due to many circulation links. By sales value, some 20 percent of drugs are sold to consumers through pharmaceutical retail firms, and the rest (80 percent) are sold out through hospitals (including hospitals, community and township hospitals), according to Research and Markets.

    EDITOR'S CHOICE | 19 March 2012

  • Vietnam will continue to rely heavily on pharmaceutical imports

    Despite strong growth potential, the government's protectionist policy of preventing foreign owned companies from distributing their products and other regulatory inefficiencies will continue to hinder the development of the pharmaceutical sector in the country.

    EDITOR'S CHOICE | 16 March 2012

  • Xceleron announces move to purpose-built laboratories

    Xceleron announced that existing investors Albion Ventures and Solon Ventures have invested US$2.4 million to locate all of the company’s business in its custom-built facility in Germantown, MD.

    EDITOR'S CHOICE | 09 March 2012

  • Generic drug manufacturers forge alliances in face of tough economic climate

    The generic drugs sector’s role as the provider of affordable drugs has widely benefitted public and private health payers keen to control costs. But in the current economic climate, downward pressure on prices is impacting the generic sector, with increases in acquisition and strategic partnering now firmly part of the competitive landscape.

    EDITOR'S CHOICE | 28 February 2012

Page 1 Next > Last >>